Maojo et al 84. Bizer C. The emerging web of linked data. IEEE Intell Syst. 2009; 24(5):87–92. 85. Renear AH, Palmer CL. Strategic reading, ontologies, and the future of scientific publishing. Science. 2009;325(5942):828–832. 86. Spasic I, Ananiadou S, McNaught J, Kumar A. Text mining and ontologies in biomedicine: making sense of raw text. Brief Bioinform. 2005;6(3):239–251. 87. Gordon N, Sagman U. Nanomedicine Taxonomy [briefing paper]. Ottawa: Canadian Institute of Health Research and Canadian NanoBusiness Alliance; 2003. 88. Thomas DG, Pappu RV, Baker NA. NanoParticle Ontology for cancer nanotechnology research. J Biomed Inform. 2011;44(1): 59–74. 89. Alonso-Calvo R, Maojo V, Billhardt H, Martin-Sanchez F, García- Remesal M, Pérez-Rey D. An agent- and ontology-based system for integrating public gene, protein, and disease databases. J Biomed Inform. 2007;40(1):17–29. 90. McCusker JP, Phillips JA, González Beltrán A, Finkelstein A, Krauthammer M. Semantic web data warehousing for caGrid. BMC Bioinformatics. 2009;10 Suppl 10:S2. 91. Stokes TH, Phan J, Quo CF, Nie S, Wang MD. Bio-nano-informatics: an integrated information management system for personalized o n c o l og y. C o n f P ro c I E E E E n g M e d B i o l S o c . 2 0 0 6 ; 1 : 3325–3328. 92. Papagiannaros A, Levchenko T, Hartner W, Mongayt D, Torchilin V. Quantum dots encapsulated in phospholipid micelles for imaging and quantification of tumors in the near-infrared region. Nanomedicine. 2009;5(2):216–224. 93. Gao X, Yang L, Petros JA, Marshall FF, Simons JW, Nie S. In vivo molecular and cellular imaging with quantum dots. Curr Opin Biotechnol. 2005;16(1):63–72. 94. Baker JR Jr. The need to pursue and publish clinical trials in nanomedicine. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2011;3(4):341–342. 95. Lanza GM, Yu X, Winter PM, et al. Targeted antiproliferative drug delivery to vascular smooth muscle cells with a magnetic resonance imaging nanoparticle contrast agent: implications for rational therapy of restenosis. Circulation. 2002;106(22):2842–2847. 96. Chrastina A, Schnitzer JE. Iodine-125 radiolabeling of silver nanoparticles for in vivo SPECT imaging. Int J Nanomedicine. 2010; 5:653–659. 97. Reuveni T, Motiei M, Romman Z, Popovtzer A, Popovtzer R. Targeted gold nanoparticles enable molecular CT imaging of cancer: an in vivo study. Int J Nanomedicine. 2011;6:2859–2864. 98. Sperling RA, Gil PR, Zhang F, Zanella M, Parak WJ. Biological applications of gold nanoparticles. Chem Soc Rev. 2008;37: 1896–1908. 99. Vargas K, Driscoll J. Computational Nanoscience: Applications for Molecules, Clusters, and Solids. Cambridge: Cambridge University Press; 2011. 100. Archakov AI, Ivanov YD. Analytical nanobiotechnology for medicine diagnostics. Mol Biosyst. 2007;3(5):336–342. 101. Bewick S,Yang R, Zhang M. Complex mathematical models of biology at the nanoscale. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2009;1(6):650–659. 102. Jaramillo-Botero A, Abrol R, van Duin A, Goddard WA III. Multiscale-multiparadigm modeling and simulation of nanometer scale systems and processes for nanomedical applications. In: Zhang M, Xi N, editors. Nanomedicine: A Systems Engineering Approach. Singa- pore: Pan Stanford Publishing; 2009:245–300. 103. Chaimovich A, Shell MS. Coarse-graining errors and numerical optimization using a relative entropy framework. J Chem Phys. 2011; 134(9):094112. 104. Cachau RE, Gonzalez-IbanezAM, Gonzalez-Nilo FD.The collaboratory for structural nanobiology. Nanotech. 2010;3:238–241. Dovepress 105. de la Calle G, García-Remesal M, Chiesa S, de la Iglesia D, Maojo V. BIRI: a new approach for automatically discovering and indexing available public bioinformatics resources from the literature. BMC Bioinformatics. 2009;10:320. 106. García-Remesal M, Cuevas A, Pérez-Rey D, et al. PubDNA Finder: a web database linking full-text articles to sequences of nucleic acids. Bioinformatics. 2010;26(21):2801–2802. 107. García-Remesal M, Maojo V, Crespo J, Billhardt H. Logical schema acquisition from text-based sources for structured and non-structured biomedical sources integration. AMIA Annu Symp Proc. 2007; 2007:259–263. 108. Ai J, Biazar E, Jafarpour M, et al. Nanotoxicology and nanoparticle safety in biomedical designs. Int J Nanomedicine. 2011;6: 1117–1127. 109. Webster TJ. NanoTox: hysteria or scientif ic studies? Int J Nanomedicine. 2008;3(2):i–ii. 110. Lai DY. Toward toxicity testing of nanomaterials in the 21st century: a paradigm for moving forward. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2012;4(1):1–15. 111. Adiseshaiah PP, Hall JB, McNeil SE. Nanomaterial standards for efficacy and toxicity assessment. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010;2(1):99–112. 112. Oberdörster G, Oberdörster E, Oberdörster J. Concepts of nanoparticle dose metric and response metric. Environ Health Perspect. 2007; 115(6):A290. 113. Hussain S, Vanoirbeek JA, Hoet PH. Interactions of nanomaterials with the immune system. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2012;4(2):169–183. 114. ISA Commons. What is the ISA framework? In: ISA Commons [homepage on the Internet]. 2011. Available from: http://isacommons. org/. Accessed April 30, 2012. 115. Minimum Information for Nanomaterial Characterization (MINChar) Initiative. Characterization Matters [homepage on the Internet]. 2008. Available from: http://characterizationmatters.org/. Accessed February 28, 2011. 116. Aillon KL, Xie YM, El-Gendy N, Berkland CJ, Forrest ML. Effects of nanomaterial physicochemical properties on in vivo toxicity. Adv Drug Delivery Rev. 2009;61(6):457–466. 117. Peng RD. Reproducible research in computational science. Science. 2011;334(6060):1226–1227. 118. Hasman A, Ammenwerth E, Dickhaus H, et al. Biomedical informatics – a confluence of disciplines? Methods Inf Med. 2011;50(6): 508–524. 119. Kjølberg KL, Strand R. Conversations about responsible nanoresearch. Nanoethics. 2011;5(1):99–113. 120. Sandhiya S, Dkhar SA, Surendiran A. Emerging trends of nanomedicine – an overview. Fundam Clin Pharmacol. 2009;23(3): 263–269. 121. Rosse C, Mejino JL Jr. A reference ontology for biomedical informatics: the Foundational Model of Anatomy. J Biomed Inform. 2003;36(6):478–500. 122. Garten Y, Altman RB. Pharmspresso: a text mining tool for extraction of pharmacogenomics concepts and relationships from full text. BMC Bioinformatics. 2009;10 Suppl 2:S6. 123. Maojo V, Crespo J, García-Remesal M, de la Iglesia D, Perez-Rey D, Kulikowski C. Biomedical ontologies: toward scientific debate. Meth- ods Inf Med. 2011;50(3):203–216. 124. Ito JI, Tabei Y, Shimizu K, Tomii K, Tsuda K. PDB-scale analysis of known and putative ligand-binding sites with structural sketches. Proteins. 2012;80(3):747–763. 125. Riehemann K, Schneider SW, Luger TA, Godin B, Ferrari M, Fuchs H. Nanomedicine – challenge and perspectives. Angew Chem Int Ed Engl. 2009;48(5):872–897. 3884 submit your manuscript | www.dovepress.com Dovepress International Journal of Nanomedicine 2012:7